Literature DB >> 19513557

MicroRNA profiling of human kidney cancer subtypes.

David Petillo1, Eric J Kort, John Anema, Kyle A Furge, Ximing J Yang, Bin Tean Teh.   

Abstract

Although the functions of most of the identified microRNAs (miRNAs) have yet to be determined, their use as potential biomarkers has been considered in several human diseases and cancers. In order to understand their role in renal tumorigenesis, we screened the expression levels of miRNAs in four subtypes of human renal neoplasms: clear cell, papillary, and chromophobe renal cell carcinomas (RCC) as well as benign renal oncocytomas. We found a unique miRNA signature for each subtype of renal tumor. Furthermore, we identified unique patterns of miRNA expression distinguishing clear cell RCC cases with favorable vs. unfavorable outcome. Specifically, we documented the overexpression of miRs 424 and 203 in clear cell RCC relative to papillary RCC, as well as the inversion of expression of miR-203 in the benign oncocytomas (where it is underexpressed relative to normal kidney) as compared to the malignant chromophobe RCC (where it is overexpressed relative to normal kidney). Our results further suggest that overexpression of S-has-miR-32 is associated with poor outcome. While previous studies have identified unique miRNA expression pattern distinguishing tumors from different anatomical locations, here we extend this principle to demonstrate the utility of miRNA expression profiling to identify a signature unique to various tumor subtypes at a single anatomic locus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513557     DOI: 10.3892/ijo_00000318

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  73 in total

Review 1.  Translational study of microRNAs and its application in kidney disease and hypertension research.

Authors:  Alison J Kriegel; Domagoj Mladinov; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

Review 2.  Metastamirs: a stepping stone towards improved cancer management.

Authors:  Nicole M A White; Eman Fatoohi; Maged Metias; Klaus Jung; Carsten Stephan; George M Yousef
Journal:  Nat Rev Clin Oncol       Date:  2010-11-02       Impact factor: 66.675

Review 3.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

4.  MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients.

Authors:  Julia Kovacova; Jaroslav Juracek; Alexandr Poprach; Jindrich Kopecky; Ondrej Fiala; Marek Svoboda; Pavel Fabian; Lenka Radova; Petr Brabec; Tomas Buchler; Ondrej Slaby
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

5.  miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.

Authors:  Guanghui Hu; Peng Lai; Min Liu; Liang Xu; Zhuifeng Guo; Huan Liu; Wei Li; Gangchun Wang; Xudong Yao; Junhua Zheng; Yunfei Xu
Journal:  Tumour Biol       Date:  2014-08-15

6.  Accurate molecular classification of renal tumors using microRNA expression.

Authors:  Eddie Fridman; Zohar Dotan; Iris Barshack; Miriam Ben David; Avital Dov; Sarit Tabak; Orit Zion; Sima Benjamin; Hila Benjamin; Hagit Kuker; Camila Avivi; Kinneret Rosenblatt; Sylvie Polak-Charcon; Jacob Ramon; Nitzan Rosenfeld; Yael Spector
Journal:  J Mol Diagn       Date:  2010-07-01       Impact factor: 5.568

7.  Comparison of exosomal microRNAs secreted by 786-O clear cell renal carcinoma cells and HK-2 proximal tubule-derived cells in culture identifies microRNA-205 as a potential biomarker of clear cell renal carcinoma.

Authors:  Victor C Crentsil; Hui Liu; Donald F Sellitti
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

8.  DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.

Authors:  Amy A Slater; Majed Alokail; Dean Gentle; Masahiro Yao; Gyula Kovacs; Eamonn R Maher; Farida Latif
Journal:  Epigenetics       Date:  2013-02-21       Impact factor: 4.528

9.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.

Authors:  Huiqing Liu; Angela R Brannon; Anupama R Reddy; Gabriela Alexe; Michael W Seiler; Alexandra Arreola; Jay H Oza; Ming Yao; David Juan; Louis S Liou; Shridar Ganesan; Arnold J Levine; W K Rathmell; Gyan V Bhanot
Journal:  BMC Syst Biol       Date:  2010-04-27

10.  MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer.

Authors:  Nicole M A White; George M Yousef
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.